Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire

Neurological Sciences

Volumn 27, Issue 2, 2006, Pages 91-96

  Rostedt, Anna ^a   Padua, L ^b,c   Stalberg E V ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Disease specific questionnaire; MG Questionnaire; Myasthenia gravis; Patient oriented; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; ITALY; MALE; MYASTHENIA GRAVIS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SHORT FORM 36; SWEDEN; TEST RETEST RELIABILITY; TRANSCULTURAL CARE; VALIDATION PROCESS; VALIDITY;

ADULT; AGED; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SWEDEN; TRANSLATIONS;

EID: 33745629844     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0606-y     Document Type: Article

References (13)

1. Amadio PC (1993) Outcomes measurements. J Bone Joint Surg Am 75:1583-1584
2. Tonali P, Padua L, Sanguinetti C et al (1999) Outcome research and patient-oriented measures in the multiperspective assessment of neurological and musculoskeletal disorders. Consensus Conference: Third Roman Neurophysiology Day, Outcome Research in Neurology and in Musculoskeletal Disorders, 24 October 1998. Ital J Neurol Sci 20:139-140
3. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
4. Hawker G, Melfi C, Paul J et al (1995) Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol 22:1193-1196
5. Guyatt GH, Bombardier C, Tugwell PX (1986) Measuring disease-specific quality of life in clinical trials. CMAJ 134:889-895
6. Guillemin F (1995) Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol 24:61-63
7. Jaretzki A III, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16-23
8. Padua L, Evoli A, Aprile I et al (2002) Myasthenia gravis outcome measure: Development and validation of a disease-specific self-administered questionnaire. Neurol Sci 23:59-68
9. Sullivan M, Karlsson J,Ware JE Jr (1995) The Swedish SF-36 Health Survey. I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 41:1349-1358
10. Barohn RJ, McIntire D, Herbelin L et al (1998) Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 841:769-772
11. Padua L, Galassi G, Ariatti A et al (2005) Myasthenia gravis self-administered questionnaire: Development of regional domains. Neurol Sci 25:331-336
12. Ebel RL (1951) Estimation of the reliability of ratings. Psychometrika 16:407-424
13. Freedman KB, Back S, Bernstein J (2001) Sample size and statistical power of randomised, controlled trials in orthopaedics. J Bone Joint Surg Br 83:397-402